Skip to content

Author

Paweł Krawczyk

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access 2026

Efficacy and Safety of First-Line Chemoimmunotherapy with Durvalumab or Atezolizumab in Extensive-Stage of Small-Cell Lung Cancer in Real World Practice

: Background: Small-cell lung cancer (SCLC) is characterised by an aggressive clinical course and the early development of distant metastases. The introduction of immune checkpoint inhibitors to platinum-based chemotherapy has significantly improved survival outcomes. The aim of this study was to compare the efficacy a...

A. Łomża-Łaba, M. Knetki-Wróblewska, Michał Gil et al. · 0 citations
Review Open access Sep 2026

Precision Oncology in Non-Small Cell Lung Cancer: Integrating Molecular Diagnostics, Targeted Therapies, and Resistance Mechanisms

The proposed three-tiered resistance framework provides a structured basis for understanding treatment failure, guiding molecular reassessment at progression, and informing future adaptive therapeutic strategies to improve long-term patient outcomes.

Aleksandra Litkowska, Jan Wojtas, Kaja Nadulska et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.